310 related articles for article (PubMed ID: 37365631)
1. Development of complemented comprehensive networks for rapid screening of repurposable drugs applicable to new emerging disease outbreaks.
Nam Y; Lucas A; Yun JS; Lee SM; Park JW; Chen Z; Lee B; Ning X; Shen L; Verma A; Kim D
J Transl Med; 2023 Jun; 21(1):415. PubMed ID: 37365631
[TBL] [Abstract][Full Text] [Related]
2. SAveRUNNER: A network-based algorithm for drug repurposing and its application to COVID-19.
Fiscon G; Conte F; Farina L; Paci P
PLoS Comput Biol; 2021 Feb; 17(2):e1008686. PubMed ID: 33544720
[TBL] [Abstract][Full Text] [Related]
3. Signaling repurposable drug combinations against COVID-19 by developing the heterogeneous deep herb-graph method.
Yang F; Zhang S; Pan W; Yao R; Zhang W; Zhang Y; Wang G; Zhang Q; Cheng Y; Dong J; Ruan C; Cui L; Wu H; Xue F
Brief Bioinform; 2022 Sep; 23(5):. PubMed ID: 35514205
[TBL] [Abstract][Full Text] [Related]
4. Using TransR to enhance drug repurposing knowledge graph for COVID-19 and its complications.
Zhao H; Li H; Liu Q; Dong G; Hou C; Li Y; Zhao Y
Methods; 2024 Jan; 221():82-90. PubMed ID: 38104883
[TBL] [Abstract][Full Text] [Related]
5. Repurpose Open Data to Discover Therapeutics for COVID-19 Using Deep Learning.
Zeng X; Song X; Ma T; Pan X; Zhou Y; Hou Y; Zhang Z; Li K; Karypis G; Cheng F
J Proteome Res; 2020 Nov; 19(11):4624-4636. PubMed ID: 32654489
[TBL] [Abstract][Full Text] [Related]
6. Knowledge Graph-Based Approaches to Drug Repurposing for COVID-19.
Al-Saleem J; Granet R; Ramakrishnan S; Ciancetta NA; Saveson C; Gessner C; Zhou Q
J Chem Inf Model; 2021 Aug; 61(8):4058-4067. PubMed ID: 34297570
[TBL] [Abstract][Full Text] [Related]
7. Network medicine framework for identifying drug-repurposing opportunities for COVID-19.
Morselli Gysi D; do Valle Í; Zitnik M; Ameli A; Gan X; Varol O; Ghiassian SD; Patten JJ; Davey RA; Loscalzo J; Barabási AL
Proc Natl Acad Sci U S A; 2021 May; 118(19):. PubMed ID: 33906951
[TBL] [Abstract][Full Text] [Related]
8. Drug repurposing for COVID-19 using graph neural network and harmonizing multiple evidence.
Hsieh K; Wang Y; Chen L; Zhao Z; Savitz S; Jiang X; Tang J; Kim Y
Sci Rep; 2021 Nov; 11(1):23179. PubMed ID: 34848761
[TBL] [Abstract][Full Text] [Related]
9. Drug repurposing for COVID-19 via knowledge graph completion.
Zhang R; Hristovski D; Schutte D; Kastrin A; Fiszman M; Kilicoglu H
J Biomed Inform; 2021 Mar; 115():103696. PubMed ID: 33571675
[TBL] [Abstract][Full Text] [Related]
10. Drug repurposing with network reinforcement.
Nam Y; Kim M; Chang HS; Shin H
BMC Bioinformatics; 2019 Jul; 20(Suppl 13):383. PubMed ID: 31337333
[TBL] [Abstract][Full Text] [Related]
11. Drug repurposing for COVID-19 using graph neural network and harmonizing multiple evidence.
Hsieh K; Wang Y; Chen L; Zhao Z; Savitz S; Jiang X; Tang J; Kim Y
ArXiv; 2022 Feb; ():. PubMed ID: 32995367
[TBL] [Abstract][Full Text] [Related]
12. DRTerHGAT: A drug repurposing method based on the ternary heterogeneous graph attention network.
He H; Xie J; Huang D; Zhang M; Zhao X; Ying Y; Wang J
J Mol Graph Model; 2024 Jul; 130():108783. PubMed ID: 38677034
[TBL] [Abstract][Full Text] [Related]
13. A computational approach to drug repurposing using graph neural networks.
Doshi S; Chepuri SP
Comput Biol Med; 2022 Nov; 150():105992. PubMed ID: 36228466
[TBL] [Abstract][Full Text] [Related]
14. Drug Repurposing for COVID-19 using Graph Neural Network with Genetic, Mechanistic, and Epidemiological Validation.
Hsieh K; Wang Y; Chen L; Zhao Z; Savitz S; Jiang X; Tang J; Kim Y
Res Sq; 2020 Dec; ():. PubMed ID: 33330858
[TBL] [Abstract][Full Text] [Related]
15. DTSEA: A network-based drug target set enrichment analysis method for drug repurposing against COVID-19.
Su Y; Wu J; Li X; Li J; Zhao X; Pan B; Huang J; Kong Q; Han J
Comput Biol Med; 2023 Jun; 159():106969. PubMed ID: 37105108
[TBL] [Abstract][Full Text] [Related]
16. Identification of potential pan-coronavirus therapies using a computational drug repurposing platform.
Hwang W; Han N
Methods; 2022 Jul; 203():214-225. PubMed ID: 34767922
[TBL] [Abstract][Full Text] [Related]
17. Strategies to identify candidate repurposable drugs: COVID-19 treatment as a case example.
Imami AS; McCullumsmith RE; O'Donovan SM
Transl Psychiatry; 2021 Nov; 11(1):591. PubMed ID: 34785660
[TBL] [Abstract][Full Text] [Related]
18. Network bioinformatics analysis provides insight into drug repurposing for COVID-19.
Li X; Yu J; Zhang Z; Ren J; Peluffo AE; Zhang W; Zhao Y; Wu J; Yan K; Cohen D; Wang W
Med Drug Discov; 2021 Jun; 10():100090. PubMed ID: 33817623
[TBL] [Abstract][Full Text] [Related]
19. Task-driven knowledge graph filtering improves prioritizing drugs for repurposing.
Ratajczak F; Joblin M; Ringsquandl M; Hildebrandt M
BMC Bioinformatics; 2022 Mar; 23(1):84. PubMed ID: 35246025
[TBL] [Abstract][Full Text] [Related]
20. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
